Biochemical correlates of reversal of hepatic coma coated with charcoal hemoperfusion.
Ten patients in stage IV hepatic encephalopathy who had not responded to conventional therapy for at least 48 hrs were treated with one or more 4 hr periods of hemoperfusion. Nine (90%) awoke, and 4 (40%) are alive to date, the survivors having acutely toxic and infective hepatic lesions. Biochemical changes that occurred were a reduction in blood ammonia of 23%, a rise in the ratio of branched chain to aromatic amino acids in blood (1.08 +/- 0.3 to 1.3 +/- 0.4), and cerebrospinal fluid (0.26 +/- 0.02 to 0.32 to 0.03), and a rise in cerebrospinal fluid cAMP from 2.3 +/- 0.7 ng/ml to 3.4 +/- 1.29 ng/ml with hemoperfusion. Administration of platelets and fresh frozen plasma restored the reduction of platelet counts of 29% towards pretreatment values.
D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000097:blood / Q000134:cerebrospinal fluid; D000641:Ammonia / Q000097:blood; D002395:Catecholamines / Q000134:cerebrospinal fluid; D002606:Charcoal / Q000627:therapeutic use*; D005260:Female; D006464:Hemoperfusion; D006501:Hepatic Encephalopathy / Q000628:therapy*; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000134:cerebrospinal fluid; D012701:Serotonin / Q000134:cerebrospinal fluid
D000596:Amino Acids; D002395:Catecholamines; D002606:Charcoal; D012701:Serotonin; D000641:Ammonia; D009638:Norepinephrine